Advertisement

Neonatology pp 1893-1917 | Cite as

Disorders of Sexual Development in Newborns

  • Antonio Balsamo
  • Paolo Ghirri
  • Silvano Bertelloni
  • Rosa T. Scaramuzzo
  • Franco D’Alberton
  • Alessandro Cicognani
  • Antonio Boldrini
Reference work entry

Abstract

The understanding, care, and treatment of newborns born with disorders of sex development conditions have evolved considerably over the last few decades. Biological assessment of atypical genitalia is based on a structured sequence of endocrine and genetic investigations, starting from a suitable history and a complete examination of the external genital anatomy. Investigations are particularly relevant in the 46,XY DSD where the diagnostic yield is less successful than in the 46,XX conditions. The era of next-generation sequencing is increasingly being applied to investigate complex medical diseases of unknown cause, including DSD. The challenge for health professionals will lie in integrating vast amounts of genetic information with phenotypes and counseling families appropriately. Regarding those who require evaluation before gender assignment is made, each “generation” of approach reflects the contemporary biological, social, and psychological understanding. The most recent generation needs to consider the significantly changed societal viewpoints regarding the acceptance and expansion beyond a binary perception of sexuality. This together with advances in genetic etiologies, surgical refinements, and psychological support should result in better care and quality of life (QoL) outcomes for patients with these conditions.

References

  1. Abacı A, Çatlı G, Berberoğlu M (2015) Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development. J Pediatr Endocrinol Metab 28(9–10):1019–1027.  https://doi.org/10.1515/jpem-2014-0522CrossRefPubMedGoogle Scholar
  2. Achermann JC, Hughes IA (2007) Disorders of sex development. In: Kronenberg H, Melmed S, Polonsky K, Larsen PR (eds) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, PhiladelphiaGoogle Scholar
  3. Ahmed SF, Bryce J, Hiort O (2014) International networks for supporting research and clinical care in the field of disorders of sex development. In: Understanding differences and disorders of sex development (DSD). Endocrine development, vol 27. pp 284–292. Karger, Basel. https://www.karger.com/Article/Abstract/363676Google Scholar
  4. Ahmed SF, Achermann JC, Arlt W et al (2016) Society for endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (revised 2015). Clin Endocrinol 84:771–788CrossRefGoogle Scholar
  5. Ainsworth C (2015) Sex redefined. Nature 518(7539):288–291. http://www.ncbi.nlm.nih.gov/pubmed/25693544CrossRefGoogle Scholar
  6. Austin J, Tamar-Mattis A, Mazur T et al (2011) DSD: when and how to tell the patient. Pediatr Endocrinol Rev 8:213–217PubMedGoogle Scholar
  7. Balsamo A, Cacciari E, Piazzi S et al (1996) Congenital adrenal hyperplasia: neonatal mass screening compared to clinical diagnosis only in the Emilia-Romagna region of Italy (1980–1995). Pediatrics 98:362–367PubMedGoogle Scholar
  8. Balsamo A, Baldazzi L, Menabò S, Cicognani A (2010) Impact of molecular genetics on congenital adrenal hyperplasia management. Sex Dev 4:233–248CrossRefGoogle Scholar
  9. Bertelloni S, Baroncelli GI, Ghirri P et al (2001) Hormonal treatment for unilateral inguinal testis: comparison of four different treatments. Horm Res 55:236–239PubMedGoogle Scholar
  10. Bertelloni S, Scaramuzzo RT, Parrini D et al (2007) Early diagnosis of 5-alpha-reductase deficiency in newborns. Sex Dev 1:147–151CrossRefGoogle Scholar
  11. Bertelloni S, Balsamo A, Giordani L et al (2009) 17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence. J Endocrinol Investig 32:666–670CrossRefGoogle Scholar
  12. Bertelloni S, Baldinotti F, Russo G, Ghirri P, Dati E, Michelucci A, Moscuzza F, Meroni S, Colombo I, Sessa MR, Baroncelli GI (2016) 5α-reductase-2 deficiency: clinical findings, endocrine pitfalls, and genetic features in a large Italian cohort. Sex Dev 10:28–36CrossRefGoogle Scholar
  13. Biason-Lauber A (2010) Control of sex development. Best Pract Res Clin Endocrinol Metab 24:163–186CrossRefGoogle Scholar
  14. Biason-Lauber A, Chaboissier MC (2015) Ovarian development and disease: the known and the unespected. Semin Cell Dev Biol 45:59–67CrossRefGoogle Scholar
  15. Biason-Lauber A, Miller WL, Pandey AV, Flück CE (2013) Of marsupials and men: backdoor dihydrotestosterone synthesis in male sexual differentiation. Mol Cell Endocrinol 371:124–132. http://www.ncbi.nlm.nih.gov/pubmed/3376007CrossRefGoogle Scholar
  16. Brain CE, Creighton SM, Mushtaq I et al (2010) Holistic management of DSD. Best Pract Res Clin Endocrinol Metab 24:335–354CrossRefGoogle Scholar
  17. Burkhard FZ, Parween S, Udhane SS, Fluck CE, Pandey AV (2016) P450 oxidoreductase deficiency: analysis of mutations and polymorphisms. J Steroid Biochem Mol Biol.  https://doi.org/10.1016/j.jsbmb.2016.04.003CrossRefGoogle Scholar
  18. Cools M, Drop SL, Wolffenbuttel KP et al (2006) Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 27:468–484CrossRefGoogle Scholar
  19. Cools M, Wolffenbuttel KP, Drop SLS, Oosterhuis JW, Looijenga LH (2011) Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev 5:167–180CrossRefGoogle Scholar
  20. Cools M, Simmonds M, Elford S, Gorter J, Ahmed SF, D’Alberton F, Springer A, Hiort O, Management Committee of the European Cooperation in Science and Technology Action BM1303 (2016) Response to the council of Europe human rights commissioner’s issue paper on human rights and intersex people. Eur Urol.  https://doi.org/10.1016/j.eururo.2016.05.015. pii: S0302–2838(16): 30179-8 [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/27210458CrossRefGoogle Scholar
  21. D’Alberton F (2010) Disclosing DSD and opening the doors. Sex Dev 4:304–309CrossRefGoogle Scholar
  22. D’Alberton F et al (2015) Quality of life and psychological adjustment of women living with 46, XY differences of sex development. J Sex Med 12(6):1440–1449CrossRefGoogle Scholar
  23. di Clemente N, Belville C (2006) Anti-Müllerian hormone receptor defect. Best Pract Res Clin Endocrinol Metab 20:599–610CrossRefGoogle Scholar
  24. Elsheikh M, Dunger DB, Conway GS, Wass JA (2002) Turner’s syndrome in adulthood. Endocr Rev 23:120–140PubMedGoogle Scholar
  25. Ferraz-de Souza B, Lin L, Acherman JC (2011) Steroidogenic factor 1 (SF1, NR5A1) and human diseases. Mol Cell Endocrinol 336:198–205CrossRefGoogle Scholar
  26. Ghirri P, Ciulli C, Vuerich M et al (2002) Incidence at birth and natural history of cryptorchidism: a study of 10,730 consecutive male infants. J Endocrinol Investig 25:709–715CrossRefGoogle Scholar
  27. Ghirri P, Scaramuzzo RT, Bertelloni S et al (2009) Prevalence of hypospadias in Italy according to severity, gestational age and birthweight: an epidemiological study. Riv Ital Pediatr 35:18CrossRefGoogle Scholar
  28. Ghirri P, Scaramuzzo MR, Greggio N, Salerno MC (2015) (Italian) Protocollo diagnostico e management in età neonatale. In: http://www.gruppodistudio-it-dsd.org/diffsvilup/32_protoc_neonatale_dsd.pdf
  29. Gillam LH, Hewitt JK, Warne GL (2010) Ethical principles for the management of infants with DSD. Horm Res Paediatr 74:412–418CrossRefGoogle Scholar
  30. Hewitt J, Zacharin M (2015) Hormone replacement in disorders of sex development: current thinking. Best Pract Res Clin Endocrinol Metab 29:437e447CrossRefGoogle Scholar
  31. Hsu LY, Benn PA (1999) Revised guidelines for the diagnosis of mosaicism in amniocytes. Prenat Diagn 19:1081–1082CrossRefGoogle Scholar
  32. Hughes IA, Deeb A (2006) Androgen resistance. Best Pract Res Clin Endocrinol Metab 20:577–598CrossRefGoogle Scholar
  33. Hughes IA, Lim HN, Martin H et al (2001) Developmental aspects of androgen action. Mol Cell Endocrinol 185:33–41CrossRefGoogle Scholar
  34. Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT (2007) Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res Clin Endocrinol Metab 21:351–365CrossRefGoogle Scholar
  35. Imperato-McGinley J, Zhu YS (2002) Androgens and male physiology the syndrome of 5-alpha-reductase-2 deficiency. Mol Cell Endocrinol 198:51–59CrossRefGoogle Scholar
  36. Janjua NR, Frederiksen H, Skakkebaek NE et al (2008) Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans. Int J Androl 31:118–130CrossRefGoogle Scholar
  37. Joint LWPES/ESPE CAH Working Group (2002) Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins pediatric endocrine society and the European society for paediatric endocrinology. J Clin Endocrinol Metab 87:4048–4053CrossRefGoogle Scholar
  38. Jones ME, Boon WC, McInnes K et al (2007) Recognizing rare disorders: aromatase deficiency. Nat Clin Pract Endocrinol Metab 3:414–421CrossRefGoogle Scholar
  39. Jurgensen M, Kleinemeier E, Lux A et al (2010) Psychosexual development in children with DSD: results from the German clinical evaluation study. J Pediatr Endocrinol Metab 23:565–578CrossRefGoogle Scholar
  40. Kalfa N, Philibert P, Baskin LS, Sultan C (2011) Hypospadias: interactions between environment and genetics. Mol Cell Endocrinol 335:89–95CrossRefGoogle Scholar
  41. Kleinemeier E, Jurgensen M, Lux A et al (2010) Psychological adjustment and sexual development of adolescents with DSD. J Adolesc Health 47:463–471CrossRefGoogle Scholar
  42. Kolesinska Z, Ahmed SF, Niedziela M, Bryce J, Molinska-Glura M, Rodie M, Jiang J, Sinnott RO, Hughes IA, Darendeliler F, Hiort O, van der Zwan Y, Cools M, Guran T, Holterhus PM, Bertelloni S, Lisa L, Arlt W, Krone N, Ellaithi M, Balsamo A, Mazen I, Nordenstrom A, Lachlan K, Alkhawari M, Chatelain P, Weintrob N (2014) Changes over time in sex assignment for disorders of sex development. Pediatrics 134(3):e710–e715.  https://doi.org/10.1542/peds.2014-1088. Epub 4 Aug 2014. http://www.ncbi.nlm.nih.gov/pubmed/25092939CrossRefGoogle Scholar
  43. Lajic S, Nordenström A, Hirvikoski T (2008) Long-term outcome of prenatal treatment of congenital adrenal hyperplasia. Endocr Dev 13:82–98CrossRefGoogle Scholar
  44. Latronico AC, Arnhold IJ (2006) Inactivating mutations of LH and FSH receptors–from genotype to phenotype. Pediatr Endocrinol Rev 4:28–31PubMedGoogle Scholar
  45. Lee YS, Cheng AW, Ahmed SF (2007) Genital anomalies in Klinefelter’s syndrome. Horm Res 68:150–155PubMedGoogle Scholar
  46. Mac Laughlin DT, Danahoe PK (2004) Sex determination and differentiation. N Engl J Med 350:367–378CrossRefGoogle Scholar
  47. Manna PR, Stocco DM (2005) Regulation of the steroidogenic acute regulatory protein expression: functional and physiological consequences. Curr Drug Targets Immune Endocr Metabol Disord 5:93–108CrossRefGoogle Scholar
  48. Massart F, Saggese G (2009) Sex steroidal targets & genetic susceptibility to idiopathic cryptorchidism. Pediatr Endocrinol Rev 6:481–490PubMedGoogle Scholar
  49. McCarty MM (2008) Estradiol and the developing brain. Physiol Rev 88:91–124CrossRefGoogle Scholar
  50. Menabò S, Balsamo A, Nicoletti A et al (2008) Three novel AMH gene mutations in a patient with persistent müllerian duct syndrome and normal AMH serum dosage. Horm Res 70:124–128CrossRefGoogle Scholar
  51. Menabò S, Polat S, Baldazzi L, Kulle AE, Holterhus PM, Grötzinger J, Fanelli F, Balsamo A, Riepe FG (2014) Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations. Eur J Hum Genet 22(5):610–616.  https://doi.org/10.1038/ejhg.2013.197. Epub 11 Sep 2013. PubMed PMID: 24022297; PubMed Central PMCID: PMC3992560. http://www.ncbi.nlm.nih.gov/pubmed/24022297CrossRefGoogle Scholar
  52. Mendonca BB, Domenice S, Arnhold IJP, Costa EMF (2009) 46, XY disorders of sex development (DSD). Clin Endocrinol 70:173–187Google Scholar
  53. Meyer-Bahlburg HFL et al (2016) Gender assignment, reassignment and outcome in disorders of sex development: update of the 2005 consensus conference. Horm Res Paediatr 85(2):112–118CrossRefGoogle Scholar
  54. Migeon CJ, Berkovitz DG, Brown TR (1994) Sexual differentiation and ambiguity. In: Kappy MS, Blizzard RM, Migeon CJ (eds) The diagnosis and treatment of endocrine disorders in childhood and adolescence, 4th edn. Thomas, SpringfieldGoogle Scholar
  55. Nabhan ZM, Lee PA (2007) Disorder of sex development. Curr Opin Obstet Gynecol 19:440–445CrossRefGoogle Scholar
  56. Nielsen J, Wohlert M (1991) Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87:81–83CrossRefGoogle Scholar
  57. Nihoul-Fekete C, Lortat-Jacob S, Cachin O, Josso N (1984) Preservation of gonadal function in true hermaphroditism. J Pediatr Surg 19:50–55CrossRefGoogle Scholar
  58. Polizzi A, Balsamo A, Bal MO, Taruscio D (2014) Rare diseases research and practice. Endocr Dev 27:234–256. http://www.ncbi.nlm.nih.gov/pubmed/25247660
  59. Saggese G, Ghirri P, Gabrielli S, Cosenza GC (1989) Hormonal therapy for cryptorchidism with a combination of human chorionic gonadotropin and follicle-stimulating hormone. Success and relapse rate. Am J Dis Child 143:980–982CrossRefGoogle Scholar
  60. Samtani R, Bajpai M, Ghosh PK, Saraswathy KN (2010) SRD5A2 gene mutations – a population-based review. Pediatr Endocrinol Rev 8(1):34–40PubMedGoogle Scholar
  61. Sax L (2002) How common is intersex? A response to Anne Fausto- Sterling. J Sex Res 39:174–178CrossRefGoogle Scholar
  62. Schweizer K et al (2014) Gender experience and satisfaction with gender allocation in adults with diverse intersex conditions (divergences of sex development, DSD). Psychol Sex 5(1):56–82Google Scholar
  63. Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, Park WS, Lee SY (2014) Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation. J Perinat Med 42(1):121–127. http://www.ncbi.nlm.nih.gov/pubmed/23989111
  64. Shearer BM, Thorland EC, Gonzales PR, Ketterling RP (2007) Evaluation of a commercially available focused aCGH platform for the detection of constitutional chromosome anomalies. Am J Med Genet A 143:2357–2370CrossRefGoogle Scholar
  65. Simm D, Degenhardt K, Gerdemann C et al (2008) Chronological age of patients with Turner syndrome at diagnosis. Klin Padiatr 220:16–20CrossRefGoogle Scholar
  66. Slowikowska-Hilczer J, Szarras-Czapnik M, Wolski JK, Oszukowska E, Hilczer M, Jakubowski L, Walczak-Jedrzejowska R, Marchlewska K, Filipiak E, Kaluzewski B, Baka-Ostrowska M, Niedzielski J, Kula K (2015) The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients. Folia Histochem Cytobiol 53(3):218–226CrossRefGoogle Scholar
  67. Speiser PW (2007) Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia. Horm Res 68(Suppl 5):90–92PubMedGoogle Scholar
  68. Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349:776–788CrossRefGoogle Scholar
  69. Telvi L, Lebbar A, Del Pino O (1999) 45,X/46,XY mosaicism: report of 27 cases. Pediatrics 104(2 Part 1):304–308CrossRefGoogle Scholar
  70. Toppari J (2008) Environmental endocrine disrupters. Sex Dev 2:260–267CrossRefGoogle Scholar
  71. Turcu AF, Auchus RJ (2015) The next 150 years of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 153:63–71CrossRefGoogle Scholar
  72. Warne GL (2008) Long-term outcome of disorders of sex development. Sex Dev 2:268–277CrossRefGoogle Scholar
  73. Warne G, Raza J (2008) Disorders of sex development (DSDs), their presentation and management in different cultures. Rev Endocr Metab Disord 9:227–236CrossRefGoogle Scholar
  74. Wittassek M, Angerer J (2008) Phthalates: metabolism and exposure. Int J Androl 31:131–138CrossRefGoogle Scholar
  75. Wohlfahrt-Veje C, Main KM, Skakkebæk NE (2009) Testicular dysgenesis syndrome; fetal origin of adult reproductive problems. Clin Endocrinol 71:459–465CrossRefGoogle Scholar
  76. Yamada G, Satoh Y, Baskin LS, Cunha GR (2003) Cellular and molecular mechanisms of development of external genitalia. Differentiation 71:445–470CrossRefGoogle Scholar
  77. Zimmermann B, Zhong XY, Holzgreve W et al (2007) Real-time quantitative polymerse chain reaction measurement of male fetal DNA in maternal plasma. Methods Mol Med 132:43–49CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Medical and Surgical Sciences, Pediatric Unit, Center for Rare Endocrine Diseases (CARENDO BO)S.Orsola Malpighi University HospitalBolognaItaly
  2. 2.Neonatology and Neonatal Intensive Care UnitSanta Chiara University HospitalPisaItaly
  3. 3.Adolescent Medicine Unit, Division of PediatricsS. Chiara Hospital, University of PisaPisaItaly
  4. 4.Department of Clinical and Experimental Medicine, Division of Neonatology and Neonatal Intensive Care UnitSanta Chiara University HospitalPisaItaly

Personalised recommendations